level (<30 ng/ml). This demonstrates continued improvement in monitoring and supplementation as well as a sustained workflow (Figure 1). Cohort 2 included 162 patients: 85 autologous and 77 allogeneic. A vitamin D level was performed within 100 days of HSCT in 46% of patients and 19% were VDD. At 6 months post HSCT, 41% had a vitamin D level checked and 30% were VDD. Comparison with pretransplant levels showed that 87% of patients within 100 days and 82% of patients within 6 months had an increase in vitamin D level (Figure 2). Discussion & Implications: The results demonstrate sustained compliance over a two-year time frame of consistent monitoring and supplementation of vitamin D during the peritransplant period. There was a decrease in monitoring at later time points around 100 days and 6 months post HSCT that could be attributed to various factors, however, more follow up is needed. The findings show an increase in Vitamin D sufficiency for patients monitored and maintained on HSCT-Vitamin D specific algorithm post HSCT. Further study is needed to investigate factors which contribute to persistent VDD in a subset of HSCT patients and the impact of vitamin D monitoring/supplementations on long-term HSCT complications. NURSING (RESEARCH)
practitioners (NP) screen all donors and determine eligibility based on a history and physical, review of a Health History Questionnaire (HHQ), and various diagnostic tests. The Foundation for the Accreditation of Cellular Therapy (FACT), set standards of operation to promote quality medical and laboratory practice in hematopoietic transplantation and other cellular therapy products. Adherence to the FACT standards helps to ensure donor eligibility thereby reducing the risks of transmissible diseases. The HHQ guides the NP in determining donor eligibility. A retrospective chart review of 46 medical records from January 2011 through December 2011 revealed the rate of accuracy of 60% in determining donor eligibility based upon FACT criteria. All donors (46) were deemed as eligible; however, only 28 met FACT criteria for eligibility. Eighteen patients were ineligible; yet they were medically acceptable to donate. Reasons for ineligibility included: a missing or incomplete HHQ, a tattoo within a year, donor lived in Europe. NPs were re-educated regarding FACT criteria and how to use the HHQ when determining eligibility. A tool provided a guideline for the NPs highlighting special considerations for donors that would make them potentially ineligible. Following these interventions, the rate of accuracy improved to 84%. From June 2012 to September 2012, 19 medical records were reviewed 16 met FACT criteria for eligibility. By re-educating NPs about FACT guidelines, NPs were able to utilize the HHQ as a crucial step in their assessment process and improve the rate of accuracy in determining donor eligibility thus improving donor screening.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.